Aethlon Medical, Inc.
AEMD
$1.59
$0.042.58%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 8.51M | 9.34M | 10.70M | 11.58M | 11.85M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 8.51M | 9.34M | 10.70M | 11.58M | 11.85M |
| Operating Income | -8.51M | -9.34M | -10.70M | -11.58M | -11.85M |
| Income Before Tax | -12.58M | -13.39M | -9.56M | -11.27M | -11.50M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -12.58 | -13.39 | -9.56 | -11.27 | -11.50 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -12.58M | -13.39M | -9.56M | -11.27M | -11.50M |
| EBIT | -8.51M | -9.34M | -10.70M | -11.58M | -11.85M |
| EBITDA | -8.18M | -9.00M | -10.35M | -11.23M | -11.49M |
| EPS Basic | -6.91 | -8.82 | -12.78 | -22.80 | -30.96 |
| Normalized Basic EPS | -4.32 | -5.51 | -9.66 | -14.18 | -19.28 |
| EPS Diluted | -6.91 | -8.82 | -12.78 | -22.80 | -30.96 |
| Normalized Diluted EPS | -4.32 | -5.51 | -9.66 | -14.18 | -19.28 |
| Average Basic Shares Outstanding | 7.38M | 6.24M | 4.75M | 3.32M | 1.88M |
| Average Diluted Shares Outstanding | 7.38M | 6.24M | 4.75M | 3.32M | 1.88M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |